On the back of the synergies of the acquired Unichem portfolio, drug maker Torrent Pharmaceuticals Ltd posted a consolidated profit before tax (PBT) of Rs 293 crore for the quarter ended March 30, 2020. In Q4FY19, the company had posted a consolidated loss before tax of Rs 150 crore.
The company saw its total consolidated revenue in Q4FY20 at Rs 1961 crore, up by a marginal 4.69 per cent over Rs 1873 crore in Q4FY19. For the full financial year, while Torrent Pharma posted an over 110 per cent growth in its consolidated PBT at Rs 1187 crore in FY20, up